Penile Cancer: EAU-ASCO Collaborative Guidelines Update Q and A
Authors:
- Members Of The Eau-Asco Penile Cancer Update PanelMPMembers Of The Eau-Asco Penile Cancer Update Panel
- Maarten AlbersenMAMaarten Albersen
- 1 January 2024
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 20 (1) , 33-37
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)British Journal of Cancer, 2013
- Cisplatin and 5‐fluorouracil in inoperable, stage IV squamous cell carcinoma of the penisBJU International, 2012
- Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancerUrology Annals, 2012
- p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistencyHead & Neck, 2011
- Proof of Activity of Anti–Epidermal Growth Factor Receptor–Targeted Therapy for Relapsed Squamous Cell Carcinoma of the PenisJournal of Clinical Oncology, 2011
- Value of p16INK4a in the Pathology of Invasive Penile Squamous Cell CarcinomasAmerican Journal of Surgical Pathology, 2011
- Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II StudyJournal of Clinical Oncology, 2010
- A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)Annals of Oncology, 2008
- Preoperative Lymphoscintigraphy and Dynamic Sentinel Node Biopsy for Staging Penile Cancer: Results With Pathological CorrelationJournal of Urology, 2007
- Neoadjuvant Chemotherapy Followed by Aggressive Surgical Consolidation for Metastatic Penile Squamous Cell CarcinomaJournal of Urology, 2007